• Covid-19
  • Travel Protocols
  • Immigration & Customs Form
Monday, August 4, 2025
SKNIS
  • Home
  • About
  • Press Releases
  • Parliament
  • In The News
  • Bills
No Result
View All Result
SKNIS
No Result
View All Result
Home Featured

OXFORD UNIVERSITY/ASTRAZENECA VACCINE CAN BE USED BY ALL ADULTS—HELPS PREVENT SEVERE SYMPTOMS OF NEW COVID-19 VARIANTS

SKNISEditor by SKNISEditor
February 11, 2021
in Featured, In The News
OXFORD UNIVERSITY/ASTRAZENECA VACCINE CAN BE USED BY ALL ADULTS—HELPS PREVENT SEVERE SYMPTOMS OF NEW COVID-19 VARIANTS
Share on FacebookShare on Twitter

Related posts

PRIME MINISTER DREW AND DEPUTY PRIME MINISTER HANLEY TOUR RECONSTRUCTION SITE OF JOSHUA OBADIAH WILLIAMS PRIMARY SCHOOL 

PRIME MINISTER DREW AND DEPUTY PRIME MINISTER HANLEY TOUR RECONSTRUCTION SITE OF JOSHUA OBADIAH WILLIAMS PRIMARY SCHOOL 

August 1, 2025
Government of St. Kitts and Nevis Unveils Vibrant “Independence 42” Calendar, Celebrating 42 Yearsof Sovereign Progress

Government of St. Kitts and Nevis Unveils Vibrant “Independence 42” Calendar, Celebrating 42 Yearsof Sovereign Progress

August 1, 2025

Basseterre, St. Kitts, February 11, 2021 (SKNIS): According to the Financial Times, which is an international daily newspaper printed in broadsheet and published digitally that focuses on business and economic current affairs, the World Health Organization’s (WHO’s) Strategic Advisory Group of Experts on Immunization (Sage) has stated that the Oxford/AstraZeneca Vaccine can be used by all adults, even the elderly, worldwide.

Chief Medical Officer, Dr. Hazel Laws, reported this during her presentation at the National Emergency Operations Centre (NEOC) Press Briefing on February 10, 2021.

“The vaccine can be used by all people over the age of 18 years in all countries,” she said. “The WHO recommends an interval of about eight to 12 weeks between the doses. It has been shown that the two-dose efficacy and immunogenicity increase with a longer inter-dose interval.”

She stated that preliminary evidence of the vaccine, which the Federation is expecting through the COVAX Facility, shows that it is effective against the variant first identified in the United Kingdom. “This is reassuring,” said Dr. Laws.

The Chief Medical Officer added that Oxford University and AstraZeneca have said that they expect this vaccine to protect against the more severe disease and death caused by the variant that was first identified in South Africa.

“This is also reassuring because preliminary data a few days ago found that from a trial conducted in South Africa last week, that the vaccine had reduced efficacy against mild and moderate disease caused by the variant first identified in South Africa,” she said. “So what they are saying is that it provides you protection against moderate to severe disease.”

The WHO is expected to issue an emergency use listing for this vaccine as early as this coming Monday (February 15), said Dr. Laws.

“This is important because the COVAX Facility can only distribute vaccines that have achieved World Health Organization emergency use listing,” she said. “Once this happens, we should be hopeful in terms of expecting our allocation coming out of the COVAX Facility.”
-30-

Previous Post

Livestock Meeting

Next Post

ECSRC APPROVES INVESTMENT ADVISER LICENCE

Next Post
ECSRC APPROVES INVESTMENT ADVISER LICENCE

ECSRC APPROVES INVESTMENT ADVISER LICENCE

WHAT'S HOT

PRIME MINISTER DREW AND DEPUTY PRIME MINISTER HANLEY TOUR RECONSTRUCTION SITE OF JOSHUA OBADIAH WILLIAMS PRIMARY SCHOOL 

PRIME MINISTER DREW AND DEPUTY PRIME MINISTER HANLEY TOUR RECONSTRUCTION SITE OF JOSHUA OBADIAH WILLIAMS PRIMARY SCHOOL 

August 1, 2025
Government of St. Kitts and Nevis Unveils Vibrant “Independence 42” Calendar, Celebrating 42 Yearsof Sovereign Progress

Government of St. Kitts and Nevis Unveils Vibrant “Independence 42” Calendar, Celebrating 42 Yearsof Sovereign Progress

August 1, 2025
HISTORIC INDUSTRIAL DESIGNS BILL, 2025, PASSED TO EMPOWER CREATORS AND ALIGN SAINT KITTS AND NEVIS WITH GLOBAL IP STANDARDS

HISTORIC INDUSTRIAL DESIGNS BILL, 2025, PASSED TO EMPOWER CREATORS AND ALIGN SAINT KITTS AND NEVIS WITH GLOBAL IP STANDARDS

July 31, 2025

BROWSE BY CATEGORIES

  • 2025
  • Attorney General, Ministry of Justice and Legal Affairs
  • Bills
  • Featured
  • Featured Ministry
  • Featured Top Left
  • Featured Top Right
  • Government Projects
  • Home Page Slider
  • In Focus
  • In The News
  • Interviews
  • Minister of Agriculture, Fisheries and Marine Resources; Cooperatives; Entrepreneurship and Creative Economy
  • Ministry of Education, Youth; Social Development; Gender Affairs; Aging and Disabilities
  • Ministry of Foreign Affairs, International Trade, Industry and Commerce and Consumer Affairs; Economic Development and Investment
  • Ministry of Health
  • Ministry of Public Infrastructure, Energy and Utilities; Domestic Transport; Information, Communication and Technology; and Posts
  • Ministry of Sustainable Development, Environment; Climate Action and Constituency Empowerment
  • Ministry of Tourism, Civil Aviation; International Transport; Employment and Labour; Urban Development
  • National Security
  • Notices
  • Parliament
  • PMO Press Releases
  • Post Cabinet Briefings
  • Press Conferences
  • Press Releases
  • Prime Ministers Office, Ministry of Finance; National Security; Citizenship and Immigration; Health and Social Security
  • Register of Voters
  • Round Table
  • Speeches 2025
  • The Cabinet Secretariat, Cabinet Secteatry
  • Uncategorized
  • Vacancies

LIKE US ON FACEBOOK

Facebook Pagelike Widget

LOCATION

St. Kitts Nevis Information Service
Government Headquarters
Chruch Street
Basseterre
St. Kitts
Tel:(869)467-1416

FOLLOW US

  • Government of St. Kitts & Nevis

© 2020 St. Kitts & Nevis Information Service. Developed by E-Government Unit

No Result
View All Result
  • Home

© 2020 St. Kitts & Nevis Information Service. Developed by E-Government Unit